PMC members shape and advance the future of personalized medicine.
September 20 | Molecular Pathology Economics Summit
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services, and products to benefit patients and the health system. Believing that paradigm shifts, especially in medicine, do not happen just because the science and new technologies suggest they should, PMC supports investment in and adoption of personalized medicine through education, advocacy, and evidence development.
» Strategic Plan: 2019 (PDF)
Personalized medicine is an evolving field in which physicians use diagnostic tests to determine which medical treatments will work best for each patient. By combining the data from those tests with an individual’s medical history, circumstances and values, health care providers can develop targeted treatment and prevention plans.
Some 20 institutions representing different sectors of the health system launched PMC in 2004 to improve upon medical paradigms that base treatment decisions exclusively on population averages. Today, PMC's more than 250 members are leading the movement toward personalized medicine to benefit patients and health systems around the world.
» Membership Prospectus (PDF)